Selected research
Industry Research
Fungal Drugs for Treatment of Tinea Industry Research Report 2026
Market perspective
The global Fungal Drugs for Treatment of Tinea market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Fungal Drugs for Treatment of Tinea market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Fungal Drugs for Treatment of Tinea market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Fungal Drugs for Treatment of Tinea market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Fungal Drugs for Treatment of Tinea include Tianjin Lisheng Pharmaceuticals, Teva Pharmaceuticals, Shanghai Modern Hasen (Shangqiu) Pharmaceuticals, Shandong Qilu Pharmaceuticals, Shandong Luoxin Pharmaceuticals, Shandong Jingwei Pharmaceutical, Sandoz, Johnson & Johnson and Novartis, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Fungal Drugs for Treatment of Tinea market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Fungal Drugs for Treatment of Tinea.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Fungal Drugs for Treatment of Tinea Market by Company
Tianjin Lisheng Pharmaceuticals
Teva Pharmaceuticals
Shanghai Modern Hasen (Shangqiu) Pharmaceuticals
Shandong Qilu Pharmaceuticals
Shandong Luoxin Pharmaceuticals
Shandong Jingwei Pharmaceutical
Sandoz
Johnson & Johnson
Novartis
Jiangsu Zhiyuan Pharmaceutical
Jiangsu Yunyang Group Pharmaceuticals
Hubei Hengan Fulin
Hainan Kangzhi Pharmaceuticals
Harbin Sanlian Pharmaceuticals
Guilin Huaxin Pharmaceuticals
GSK
Chengdu Beite Pharmaceuticals
Bayer
Ultratech India
Perrigo
Padagis
Kaken Pharmaceutical
Gufic Biosciences
Galderma
Bausch Health
Fungal Drugs for Treatment of Tinea Segment by Type
Topical Drugs
Oral Drugs
Fungal Drugs for Treatment of Tinea Segment by Application
Hospital Pharmacy
Online
Retail Pharmacy
Fungal Drugs for Treatment of Tinea Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Fungal Drugs for Treatment of Tinea market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Fungal Drugs for Treatment of Tinea and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Fungal Drugs for Treatment of Tinea.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Fungal Drugs for Treatment of Tinea companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
Table 5. Global Fungal Drugs for Treatment of Tinea Market Size by Type (2021-2026) & (US$ Million)
Table 6. Global Fungal Drugs for Treatment of Tinea Revenue Market Share by Type (2021-2026)
Table 7. Global Fungal Drugs for Treatment of Tinea Forecasted Market Size by Type (2027-2032) & (US$ Million)
Table 8. Global Fungal Drugs for Treatment of Tinea Revenue Market Share by Type (2027-2032)
Table 9. Global Fungal Drugs for Treatment of Tinea Market Size by Application (2021-2026) & (US$ Million)
Table 10. Global Fungal Drugs for Treatment of Tinea Revenue Market Share by Application (2021-2026)
Table 11. Global Fungal Drugs for Treatment of Tinea Forecasted Market Size by Application (2027-2032) & (US$ Million)
Table 12. Global Fungal Drugs for Treatment of Tinea Revenue Market Share by Application (2027-2032)
Table 13. Global Fungal Drugs for Treatment of Tinea Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Table 14. Global Fungal Drugs for Treatment of Tinea Market Size by Region (2021-2026) & (US$ Million)
Table 15. Global Fungal Drugs for Treatment of Tinea Market Share by Region (2021-2026)
Table 16. Global Fungal Drugs for Treatment of Tinea Forecasted Market Size by Region (2027-2032) & (US$ Million)
Table 17. Global Fungal Drugs for Treatment of Tinea Market Share by Region (2027-2032)
Table 18. Fungal Drugs for Treatment of Tinea Industry Trends
Table 19. Fungal Drugs for Treatment of Tinea Industry Drivers
Table 20. Fungal Drugs for Treatment of Tinea Industry Opportunities and Challenges
Table 21. Fungal Drugs for Treatment of Tinea Market Restraints
Table 22. Global Top Fungal Drugs for Treatment of Tinea Players by Revenue (US$ Million) & (2021-2026)
Table 23. Global Fungal Drugs for Treatment of Tinea Revenue Market Share by Players (2021-2026)
Table 24. Global Fungal Drugs for Treatment of Tinea Industry Players Ranking, 2024 VS 2025 VS 2026
Table 25. Global Key Players of Fungal Drugs for Treatment of Tinea, Headquarters and Area Served
Table 26. Global Fungal Drugs for Treatment of Tinea Players, Product Type & Application
Table 27. Global Players Market Concentration Ratio (CR5 and HHI)
Table 28. Global Fungal Drugs for Treatment of Tinea by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
Table 29. Players Mergers & Acquisitions, Expansion Plans
Table 30. North America Fungal Drugs for Treatment of Tinea Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 31. North America Fungal Drugs for Treatment of Tinea Market Size by Country (2021-2026) & (US$ Million)
Table 32. North America Fungal Drugs for Treatment of Tinea Market Size by Country (2027-2032) & (US$ Million)
Table 33. Europe Fungal Drugs for Treatment of Tinea Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 34. Europe Fungal Drugs for Treatment of Tinea Market Size by Country (2021-2026) & (US$ Million)
Table 35. Europe Fungal Drugs for Treatment of Tinea Market Size by Country (2027-2032) & (US$ Million)
Table 36. Asia Pacific Fungal Drugs for Treatment of Tinea Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 37. Asia Pacific Fungal Drugs for Treatment of Tinea Market Size by Region (2021-2026) & (US$ Million)
Table 38. Asia Pacific Fungal Drugs for Treatment of Tinea Market Size by Country (2027-2032) & (US$ Million)
Table 39. South America Fungal Drugs for Treatment of Tinea Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 40. South America Fungal Drugs for Treatment of Tinea Market Size by Country (2021-2026) & (US$ Million)
Table 41. South America Fungal Drugs for Treatment of Tinea Market Size by Country (2027-2032) & (US$ Million)
Table 42. Middle East & Africa Fungal Drugs for Treatment of Tinea Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 43. Middle East & Africa Fungal Drugs for Treatment of Tinea Market Size by Country (2021-2026) & (US$ Million)
Table 44. Middle East & Africa Fungal Drugs for Treatment of Tinea Market Size by Country (2027-2032) & (US$ Million)
Table 45. Tianjin Lisheng Pharmaceuticals Company Information
Table 46. Tianjin Lisheng Pharmaceuticals Business Overview
Table 47. Tianjin Lisheng Pharmaceuticals Revenue in Fungal Drugs for Treatment of Tinea Business (2021-2026) & (US$ Million)
Table 48. Tianjin Lisheng Pharmaceuticals Fungal Drugs for Treatment of Tinea Product Portfolio
Table 49. Tianjin Lisheng Pharmaceuticals Recent Developments
Table 50. Teva Pharmaceuticals Company Information
Table 51. Teva Pharmaceuticals Business Overview
Table 52. Teva Pharmaceuticals Revenue in Fungal Drugs for Treatment of Tinea Business (2021-2026) & (US$ Million)
Table 53. Teva Pharmaceuticals Fungal Drugs for Treatment of Tinea Product Portfolio
Table 54. Teva Pharmaceuticals Recent Developments
Table 55. Shanghai Modern Hasen (Shangqiu) Pharmaceuticals Company Information
Table 56. Shanghai Modern Hasen (Shangqiu) Pharmaceuticals Business Overview
Table 57. Shanghai Modern Hasen (Shangqiu) Pharmaceuticals Revenue in Fungal Drugs for Treatment of Tinea Business (2021-2026) & (US$ Million)
Table 58. Shanghai Modern Hasen (Shangqiu) Pharmaceuticals Fungal Drugs for Treatment of Tinea Product Portfolio
Table 59. Shanghai Modern Hasen (Shangqiu) Pharmaceuticals Recent Developments
Table 60. Shandong Qilu Pharmaceuticals Company Information
Table 61. Shandong Qilu Pharmaceuticals Business Overview
Table 62. Shandong Qilu Pharmaceuticals Revenue in Fungal Drugs for Treatment of Tinea Business (2021-2026) & (US$ Million)
Table 63. Shandong Qilu Pharmaceuticals Fungal Drugs for Treatment of Tinea Product Portfolio
Table 64. Shandong Qilu Pharmaceuticals Recent Developments
Table 65. Shandong Luoxin Pharmaceuticals Company Information
Table 66. Shandong Luoxin Pharmaceuticals Business Overview
Table 67. Shandong Luoxin Pharmaceuticals Revenue in Fungal Drugs for Treatment of Tinea Business (2021-2026) & (US$ Million)
Table 68. Shandong Luoxin Pharmaceuticals Fungal Drugs for Treatment of Tinea Product Portfolio
Table 69. Shandong Luoxin Pharmaceuticals Recent Developments
Table 70. Shandong Jingwei Pharmaceutical Company Information
Table 71. Shandong Jingwei Pharmaceutical Business Overview
Table 72. Shandong Jingwei Pharmaceutical Revenue in Fungal Drugs for Treatment of Tinea Business (2021-2026) & (US$ Million)
Table 73. Shandong Jingwei Pharmaceutical Fungal Drugs for Treatment of Tinea Product Portfolio
Table 74. Shandong Jingwei Pharmaceutical Recent Developments
Table 75. Sandoz Company Information
Table 76. Sandoz Business Overview
Table 77. Sandoz Revenue in Fungal Drugs for Treatment of Tinea Business (2021-2026) & (US$ Million)
Table 78. Sandoz Fungal Drugs for Treatment of Tinea Product Portfolio
Table 79. Sandoz Recent Developments
Table 80. Johnson & Johnson Company Information
Table 81. Johnson & Johnson Business Overview
Table 82. Johnson & Johnson Revenue in Fungal Drugs for Treatment of Tinea Business (2021-2026) & (US$ Million)
Table 83. Johnson & Johnson Fungal Drugs for Treatment of Tinea Product Portfolio
Table 84. Johnson & Johnson Recent Developments
Table 85. Novartis Company Information
Table 86. Novartis Business Overview
Table 87. Novartis Revenue in Fungal Drugs for Treatment of Tinea Business (2021-2026) & (US$ Million)
Table 88. Novartis Fungal Drugs for Treatment of Tinea Product Portfolio
Table 89. Novartis Recent Developments
Table 90. Jiangsu Zhiyuan Pharmaceutical Company Information
Table 91. Jiangsu Zhiyuan Pharmaceutical Business Overview
Table 92. Jiangsu Zhiyuan Pharmaceutical Revenue in Fungal Drugs for Treatment of Tinea Business (2021-2026) & (US$ Million)
Table 93. Jiangsu Zhiyuan Pharmaceutical Fungal Drugs for Treatment of Tinea Product Portfolio
Table 94. Jiangsu Zhiyuan Pharmaceutical Recent Developments
Table 95. Jiangsu Yunyang Group Pharmaceuticals Company Information
Table 96. Jiangsu Yunyang Group Pharmaceuticals Business Overview
Table 97. Jiangsu Yunyang Group Pharmaceuticals Revenue in Fungal Drugs for Treatment of Tinea Business (2021-2026) & (US$ Million)
Table 98. Jiangsu Yunyang Group Pharmaceuticals Fungal Drugs for Treatment of Tinea Product Portfolio
Table 99. Jiangsu Yunyang Group Pharmaceuticals Recent Developments
Table 100. Hubei Hengan Fulin Company Information
Table 101. Hubei Hengan Fulin Business Overview
Table 102. Hubei Hengan Fulin Revenue in Fungal Drugs for Treatment of Tinea Business (2021-2026) & (US$ Million)
Table 103. Hubei Hengan Fulin Fungal Drugs for Treatment of Tinea Product Portfolio
Table 104. Hubei Hengan Fulin Recent Developments
Table 105. Hainan Kangzhi Pharmaceuticals Company Information
Table 106. Hainan Kangzhi Pharmaceuticals Business Overview
Table 107. Hainan Kangzhi Pharmaceuticals Revenue in Fungal Drugs for Treatment of Tinea Business (2021-2026) & (US$ Million)
Table 108. Hainan Kangzhi Pharmaceuticals Fungal Drugs for Treatment of Tinea Product Portfolio
Table 109. Hainan Kangzhi Pharmaceuticals Recent Developments
Table 110. Harbin Sanlian Pharmaceuticals Company Information
Table 111. Harbin Sanlian Pharmaceuticals Business Overview
Table 112. Harbin Sanlian Pharmaceuticals Revenue in Fungal Drugs for Treatment of Tinea Business (2021-2026) & (US$ Million)
Table 113. Harbin Sanlian Pharmaceuticals Fungal Drugs for Treatment of Tinea Product Portfolio
Table 114. Harbin Sanlian Pharmaceuticals Recent Developments
Table 115. Guilin Huaxin Pharmaceuticals Company Information
Table 116. Guilin Huaxin Pharmaceuticals Business Overview
Table 117. Guilin Huaxin Pharmaceuticals Revenue in Fungal Drugs for Treatment of Tinea Business (2021-2026) & (US$ Million)
Table 118. Guilin Huaxin Pharmaceuticals Fungal Drugs for Treatment of Tinea Product Portfolio
Table 119. Guilin Huaxin Pharmaceuticals Recent Developments
Table 120. GSK Company Information
Table 121. GSK Business Overview
Table 122. GSK Revenue in Fungal Drugs for Treatment of Tinea Business (2021-2026) & (US$ Million)
Table 123. GSK Fungal Drugs for Treatment of Tinea Product Portfolio
Table 124. GSK Recent Developments
Table 125. Chengdu Beite Pharmaceuticals Company Information
Table 126. Chengdu Beite Pharmaceuticals Business Overview
Table 127. Chengdu Beite Pharmaceuticals Revenue in Fungal Drugs for Treatment of Tinea Business (2021-2026) & (US$ Million)
Table 128. Chengdu Beite Pharmaceuticals Fungal Drugs for Treatment of Tinea Product Portfolio
Table 129. Chengdu Beite Pharmaceuticals Recent Developments
Table 130. Bayer Company Information
Table 131. Bayer Business Overview
Table 132. Bayer Revenue in Fungal Drugs for Treatment of Tinea Business (2021-2026) & (US$ Million)
Table 133. Bayer Fungal Drugs for Treatment of Tinea Product Portfolio
Table 134. Bayer Recent Developments
Table 135. Ultratech India Company Information
Table 136. Ultratech India Business Overview
Table 137. Ultratech India Revenue in Fungal Drugs for Treatment of Tinea Business (2021-2026) & (US$ Million)
Table 138. Ultratech India Fungal Drugs for Treatment of Tinea Product Portfolio
Table 139. Ultratech India Recent Developments
Table 140. Perrigo Company Information
Table 141. Perrigo Business Overview
Table 142. Perrigo Revenue in Fungal Drugs for Treatment of Tinea Business (2021-2026) & (US$ Million)
Table 143. Perrigo Fungal Drugs for Treatment of Tinea Product Portfolio
Table 144. Perrigo Recent Developments
Table 145. Padagis Company Information
Table 146. Padagis Business Overview
Table 147. Padagis Revenue in Fungal Drugs for Treatment of Tinea Business (2021-2026) & (US$ Million)
Table 148. Padagis Fungal Drugs for Treatment of Tinea Product Portfolio
Table 149. Padagis Recent Developments
Table 150. Kaken Pharmaceutical Company Information
Table 151. Kaken Pharmaceutical Business Overview
Table 152. Kaken Pharmaceutical Revenue in Fungal Drugs for Treatment of Tinea Business (2021-2026) & (US$ Million)
Table 153. Kaken Pharmaceutical Fungal Drugs for Treatment of Tinea Product Portfolio
Table 154. Kaken Pharmaceutical Recent Developments
Table 155. Gufic Biosciences Company Information
Table 156. Gufic Biosciences Business Overview
Table 157. Gufic Biosciences Revenue in Fungal Drugs for Treatment of Tinea Business (2021-2026) & (US$ Million)
Table 158. Gufic Biosciences Fungal Drugs for Treatment of Tinea Product Portfolio
Table 159. Gufic Biosciences Recent Developments
Table 160. Galderma Company Information
Table 161. Galderma Business Overview
Table 162. Galderma Revenue in Fungal Drugs for Treatment of Tinea Business (2021-2026) & (US$ Million)
Table 163. Galderma Fungal Drugs for Treatment of Tinea Product Portfolio
Table 164. Galderma Recent Developments
Table 165. Bausch Health Company Information
Table 166. Bausch Health Business Overview
Table 167. Bausch Health Revenue in Fungal Drugs for Treatment of Tinea Business (2021-2026) & (US$ Million)
Table 168. Bausch Health Fungal Drugs for Treatment of Tinea Product Portfolio
Table 169. Bausch Health Recent Developments
Table 170. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Fungal Drugs for Treatment of Tinea Product Image
Figure 5. Global Fungal Drugs for Treatment of Tinea Market Size Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Figure 6. Global Fungal Drugs for Treatment of Tinea Market Share by Type: 2025 VS 2032
Figure 7. Topical Drugs Product
Figure 8. Oral Drugs Product
Figure 9. Global Fungal Drugs for Treatment of Tinea Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million)
Figure 10. Global Fungal Drugs for Treatment of Tinea Market Share by Application: 2025 VS 2032
Figure 11. Hospital Pharmacy Product
Figure 12. Online Product
Figure 13. Retail Pharmacy Product
Figure 14. Global Fungal Drugs for Treatment of Tinea Market Size (US$ Million), Year-over-Year: 2021-2032
Figure 15. Global Fungal Drugs for Treatment of Tinea Market Size, (US$ Million), 2021 VS 2025 VS 2032
Figure 16. Global Fungal Drugs for Treatment of Tinea Market Share by Region: 2025 VS 2032
Figure 17. Global Fungal Drugs for Treatment of Tinea Market Share by Players in 2025
Figure 18. Global Fungal Drugs for Treatment of Tinea Manufacturers Established Date
Figure 19. Global Top 5 and 10 Fungal Drugs for Treatment of Tinea Players Market Share by Revenue in 2025
Figure 20. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 21. North America Fungal Drugs for Treatment of Tinea Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 22. North America Fungal Drugs for Treatment of Tinea Market Share by Country (2021-2032)
Figure 23. United States Fungal Drugs for Treatment of Tinea Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 24. Canada Fungal Drugs for Treatment of Tinea Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 25. Mexico Fungal Drugs for Treatment of Tinea Market Share by Country (2021-2032)
Figure 26. Europe Fungal Drugs for Treatment of Tinea Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 27. Europe Fungal Drugs for Treatment of Tinea Market Share by Country (2021-2032)
Figure 28. Germany Fungal Drugs for Treatment of Tinea Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 29. France Fungal Drugs for Treatment of Tinea Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 30. U.K. Fungal Drugs for Treatment of Tinea Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 31. Italy Fungal Drugs for Treatment of Tinea Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 32. Spain Fungal Drugs for Treatment of Tinea Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 33. Russia Fungal Drugs for Treatment of Tinea Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 34. Netherlands Fungal Drugs for Treatment of Tinea Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 35. Nordic Countries Fungal Drugs for Treatment of Tinea Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 36. Asia-Pacific Fungal Drugs for Treatment of Tinea Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 37. Asia-Pacific Fungal Drugs for Treatment of Tinea Market Share by Country (2021-2032)
Figure 38. China Fungal Drugs for Treatment of Tinea Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 39. Japan Fungal Drugs for Treatment of Tinea Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 40. South Korea Fungal Drugs for Treatment of Tinea Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 41. India Fungal Drugs for Treatment of Tinea Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 42. India Fungal Drugs for Treatment of Tinea Market Share by Country (2021-2032)
Figure 43. Australia Fungal Drugs for Treatment of Tinea Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 44. China Taiwan Fungal Drugs for Treatment of Tinea Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 45. Southeast Asia Fungal Drugs for Treatment of Tinea Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 46. South America Fungal Drugs for Treatment of Tinea Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 47. South America Fungal Drugs for Treatment of Tinea Market Share by Country (2021-2032)
Figure 48. Brazil Fungal Drugs for Treatment of Tinea Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 49. Argentina Fungal Drugs for Treatment of Tinea Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 50. Chile Fungal Drugs for Treatment of Tinea Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 51. Colombia Fungal Drugs for Treatment of Tinea Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 52. Peru Fungal Drugs for Treatment of Tinea Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 53. Tianjin Lisheng Pharmaceuticals Revenue Growth Rate in Fungal Drugs for Treatment of Tinea Business (2021-2026)
Figure 54. Teva Pharmaceuticals Revenue Growth Rate in Fungal Drugs for Treatment of Tinea Business (2021-2026)
Figure 55. Shanghai Modern Hasen (Shangqiu) Pharmaceuticals Revenue Growth Rate in Fungal Drugs for Treatment of Tinea Business (2021-2026)
Figure 56. Shandong Qilu Pharmaceuticals Revenue Growth Rate in Fungal Drugs for Treatment of Tinea Business (2021-2026)
Figure 57. Shandong Luoxin Pharmaceuticals Revenue Growth Rate in Fungal Drugs for Treatment of Tinea Business (2021-2026)
Figure 58. Shandong Jingwei Pharmaceutical Revenue Growth Rate in Fungal Drugs for Treatment of Tinea Business (2021-2026)
Figure 59. Sandoz Revenue Growth Rate in Fungal Drugs for Treatment of Tinea Business (2021-2026)
Figure 60. Johnson & Johnson Revenue Growth Rate in Fungal Drugs for Treatment of Tinea Business (2021-2026)
Figure 61. Novartis Revenue Growth Rate in Fungal Drugs for Treatment of Tinea Business (2021-2026)
Figure 62. Jiangsu Zhiyuan Pharmaceutical Revenue Growth Rate in Fungal Drugs for Treatment of Tinea Business (2021-2026)
Figure 63. Jiangsu Yunyang Group Pharmaceuticals Revenue Growth Rate in Fungal Drugs for Treatment of Tinea Business (2021-2026)
Figure 64. Hubei Hengan Fulin Revenue Growth Rate in Fungal Drugs for Treatment of Tinea Business (2021-2026)
Figure 65. Hainan Kangzhi Pharmaceuticals Revenue Growth Rate in Fungal Drugs for Treatment of Tinea Business (2021-2026)
Figure 66. Harbin Sanlian Pharmaceuticals Revenue Growth Rate in Fungal Drugs for Treatment of Tinea Business (2021-2026)
Figure 67. Guilin Huaxin Pharmaceuticals Revenue Growth Rate in Fungal Drugs for Treatment of Tinea Business (2021-2026)
Figure 68. GSK Revenue Growth Rate in Fungal Drugs for Treatment of Tinea Business (2021-2026)
Figure 69. Chengdu Beite Pharmaceuticals Revenue Growth Rate in Fungal Drugs for Treatment of Tinea Business (2021-2026)
Figure 70. Bayer Revenue Growth Rate in Fungal Drugs for Treatment of Tinea Business (2021-2026)
Figure 71. Ultratech India Revenue Growth Rate in Fungal Drugs for Treatment of Tinea Business (2021-2026)
Figure 72. Perrigo Revenue Growth Rate in Fungal Drugs for Treatment of Tinea Business (2021-2026)
Figure 73. Padagis Revenue Growth Rate in Fungal Drugs for Treatment of Tinea Business (2021-2026)
Figure 74. Kaken Pharmaceutical Revenue Growth Rate in Fungal Drugs for Treatment of Tinea Business (2021-2026)
Figure 75. Gufic Biosciences Revenue Growth Rate in Fungal Drugs for Treatment of Tinea Business (2021-2026)
Figure 76. Galderma Revenue Growth Rate in Fungal Drugs for Treatment of Tinea Business (2021-2026)
Figure 77. Bausch Health Revenue Growth Rate in Fungal Drugs for Treatment of Tinea Business (2021-2026)
Scope & coverage.
Types
- Topical Drugs
- Oral Drugs
Applications
- Hospital Pharmacy
- Online
- Retail Pharmacy
Companies covered
- Tianjin Lisheng Pharmaceuticals
- Teva Pharmaceuticals
- Shanghai Modern Hasen (Shangqiu) Pharmaceuticals
- Shandong Qilu Pharmaceuticals
- Shandong Luoxin Pharmaceuticals
- Shandong Jingwei Pharmaceutical
- Sandoz
- Johnson & Johnson
- Novartis
- Jiangsu Zhiyuan Pharmaceutical
- Jiangsu Yunyang Group Pharmaceuticals
- Hubei Hengan Fulin
- Hainan Kangzhi Pharmaceuticals
- Harbin Sanlian Pharmaceuticals
- Guilin Huaxin Pharmaceuticals
- GSK
- Chengdu Beite Pharmaceuticals
- Bayer
- Ultratech India
- Perrigo
- Padagis
- Kaken Pharmaceutical
- Gufic Biosciences
- Galderma
- Bausch Health
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Fungal Drugs for Treatment of Tinea by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Topical Drugs
- 2.2.3 Oral Drugs
- 2.3 Fungal Drugs for Treatment of Tinea by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospital Pharmacy
- 2.3.3 Online
- 2.3.4 Retail Pharmacy
- 2.4 Assumptions and Limitations
3 Fungal Drugs for Treatment of Tinea Breakdown Data by Type
- 3.1 Global Fungal Drugs for Treatment of Tinea Historic Market Size by Type (2021-2026)
- 3.2 Global Fungal Drugs for Treatment of Tinea Forecasted Market Size by Type (2027-2032)
4 Fungal Drugs for Treatment of Tinea Breakdown Data by Application
- 4.1 Global Fungal Drugs for Treatment of Tinea Historic Market Size by Application (2021-2026)
- 4.2 Global Fungal Drugs for Treatment of Tinea Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Fungal Drugs for Treatment of Tinea Market Perspective (2021-2032)
- 5.2 Global Fungal Drugs for Treatment of Tinea Growth Trends by Region
- 5.2.1 Global Fungal Drugs for Treatment of Tinea Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Fungal Drugs for Treatment of Tinea Historic Market Size by Region (2021-2026)
- 5.2.3 Fungal Drugs for Treatment of Tinea Forecasted Market Size by Region (2027-2032)
- 5.3 Fungal Drugs for Treatment of Tinea Market Dynamics
- 5.3.1 Fungal Drugs for Treatment of Tinea Industry Trends
- 5.3.2 Fungal Drugs for Treatment of Tinea Market Drivers
- 5.3.3 Fungal Drugs for Treatment of Tinea Market Challenges
- 5.3.4 Fungal Drugs for Treatment of Tinea Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Fungal Drugs for Treatment of Tinea Players by Revenue
- 6.1.1 Global Top Fungal Drugs for Treatment of Tinea Players by Revenue (2021-2026)
- 6.1.2 Global Fungal Drugs for Treatment of Tinea Revenue Market Share by Players (2021-2026)
- 6.2 Global Fungal Drugs for Treatment of Tinea Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Fungal Drugs for Treatment of Tinea Head Office and Area Served
- 6.4 Global Fungal Drugs for Treatment of Tinea Players, Product Type & Application
- 6.5 Global Fungal Drugs for Treatment of Tinea Manufacturers Established Date
- 6.6 Global Fungal Drugs for Treatment of Tinea Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Fungal Drugs for Treatment of Tinea Market Size (2021-2032)
- 7.2 North America Fungal Drugs for Treatment of Tinea Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Fungal Drugs for Treatment of Tinea Market Size by Country (2021-2026)
- 7.4 North America Fungal Drugs for Treatment of Tinea Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Fungal Drugs for Treatment of Tinea Market Size (2021-2032)
- 8.2 Europe Fungal Drugs for Treatment of Tinea Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Fungal Drugs for Treatment of Tinea Market Size by Country (2021-2026)
- 8.4 Europe Fungal Drugs for Treatment of Tinea Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Fungal Drugs for Treatment of Tinea Market Size (2021-2032)
- 9.2 Asia-Pacific Fungal Drugs for Treatment of Tinea Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Fungal Drugs for Treatment of Tinea Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Fungal Drugs for Treatment of Tinea Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Fungal Drugs for Treatment of Tinea Market Size (2021-2032)
- 10.2 South America Fungal Drugs for Treatment of Tinea Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Fungal Drugs for Treatment of Tinea Market Size by Country (2021-2026)
- 10.4 South America Fungal Drugs for Treatment of Tinea Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Fungal Drugs for Treatment of Tinea Market Size (2021-2032)
- 11.2 Middle East & Africa Fungal Drugs for Treatment of Tinea Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Fungal Drugs for Treatment of Tinea Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Fungal Drugs for Treatment of Tinea Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Tianjin Lisheng Pharmaceuticals
- 12.1.1 Tianjin Lisheng Pharmaceuticals Company Information
- 12.1.2 Tianjin Lisheng Pharmaceuticals Business Overview
- 12.1.3 Tianjin Lisheng Pharmaceuticals Revenue in Fungal Drugs for Treatment of Tinea Business (2021-2026)
- 12.1.4 Tianjin Lisheng Pharmaceuticals Fungal Drugs for Treatment of Tinea Product Portfolio
- 12.1.5 Tianjin Lisheng Pharmaceuticals Recent Developments
- 12.2 Teva Pharmaceuticals
- 12.2.1 Teva Pharmaceuticals Company Information
- 12.2.2 Teva Pharmaceuticals Business Overview
- 12.2.3 Teva Pharmaceuticals Revenue in Fungal Drugs for Treatment of Tinea Business (2021-2026)
- 12.2.4 Teva Pharmaceuticals Fungal Drugs for Treatment of Tinea Product Portfolio
- 12.2.5 Teva Pharmaceuticals Recent Developments
- 12.3 Shanghai Modern Hasen (Shangqiu) Pharmaceuticals
- 12.3.1 Shanghai Modern Hasen (Shangqiu) Pharmaceuticals Company Information
- 12.3.2 Shanghai Modern Hasen (Shangqiu) Pharmaceuticals Business Overview
- 12.3.3 Shanghai Modern Hasen (Shangqiu) Pharmaceuticals Revenue in Fungal Drugs for Treatment of Tinea Business (2021-2026)
- 12.3.4 Shanghai Modern Hasen (Shangqiu) Pharmaceuticals Fungal Drugs for Treatment of Tinea Product Portfolio
- 12.3.5 Shanghai Modern Hasen (Shangqiu) Pharmaceuticals Recent Developments
- 12.4 Shandong Qilu Pharmaceuticals
- 12.4.1 Shandong Qilu Pharmaceuticals Company Information
- 12.4.2 Shandong Qilu Pharmaceuticals Business Overview
- 12.4.3 Shandong Qilu Pharmaceuticals Revenue in Fungal Drugs for Treatment of Tinea Business (2021-2026)
- 12.4.4 Shandong Qilu Pharmaceuticals Fungal Drugs for Treatment of Tinea Product Portfolio
- 12.4.5 Shandong Qilu Pharmaceuticals Recent Developments
- 12.5 Shandong Luoxin Pharmaceuticals
- 12.5.1 Shandong Luoxin Pharmaceuticals Company Information
- 12.5.2 Shandong Luoxin Pharmaceuticals Business Overview
- 12.5.3 Shandong Luoxin Pharmaceuticals Revenue in Fungal Drugs for Treatment of Tinea Business (2021-2026)
- 12.5.4 Shandong Luoxin Pharmaceuticals Fungal Drugs for Treatment of Tinea Product Portfolio
- 12.5.5 Shandong Luoxin Pharmaceuticals Recent Developments
- 12.6 Shandong Jingwei Pharmaceutical
- 12.6.1 Shandong Jingwei Pharmaceutical Company Information
- 12.6.2 Shandong Jingwei Pharmaceutical Business Overview
- 12.6.3 Shandong Jingwei Pharmaceutical Revenue in Fungal Drugs for Treatment of Tinea Business (2021-2026)
- 12.6.4 Shandong Jingwei Pharmaceutical Fungal Drugs for Treatment of Tinea Product Portfolio
- 12.6.5 Shandong Jingwei Pharmaceutical Recent Developments
- 12.7 Sandoz
- 12.7.1 Sandoz Company Information
- 12.7.2 Sandoz Business Overview
- 12.7.3 Sandoz Revenue in Fungal Drugs for Treatment of Tinea Business (2021-2026)
- 12.7.4 Sandoz Fungal Drugs for Treatment of Tinea Product Portfolio
- 12.7.5 Sandoz Recent Developments
- 12.8 Johnson & Johnson
- 12.8.1 Johnson & Johnson Company Information
- 12.8.2 Johnson & Johnson Business Overview
- 12.8.3 Johnson & Johnson Revenue in Fungal Drugs for Treatment of Tinea Business (2021-2026)
- 12.8.4 Johnson & Johnson Fungal Drugs for Treatment of Tinea Product Portfolio
- 12.8.5 Johnson & Johnson Recent Developments
- 12.9 Novartis
- 12.9.1 Novartis Company Information
- 12.9.2 Novartis Business Overview
- 12.9.3 Novartis Revenue in Fungal Drugs for Treatment of Tinea Business (2021-2026)
- 12.9.4 Novartis Fungal Drugs for Treatment of Tinea Product Portfolio
- 12.9.5 Novartis Recent Developments
- 12.10 Jiangsu Zhiyuan Pharmaceutical
- 12.10.1 Jiangsu Zhiyuan Pharmaceutical Company Information
- 12.10.2 Jiangsu Zhiyuan Pharmaceutical Business Overview
- 12.10.3 Jiangsu Zhiyuan Pharmaceutical Revenue in Fungal Drugs for Treatment of Tinea Business (2021-2026)
- 12.10.4 Jiangsu Zhiyuan Pharmaceutical Fungal Drugs for Treatment of Tinea Product Portfolio
- 12.10.5 Jiangsu Zhiyuan Pharmaceutical Recent Developments
- 12.11 Jiangsu Yunyang Group Pharmaceuticals
- 12.11.1 Jiangsu Yunyang Group Pharmaceuticals Company Information
- 12.11.2 Jiangsu Yunyang Group Pharmaceuticals Business Overview
- 12.11.3 Jiangsu Yunyang Group Pharmaceuticals Revenue in Fungal Drugs for Treatment of Tinea Business (2021-2026)
- 12.11.4 Jiangsu Yunyang Group Pharmaceuticals Fungal Drugs for Treatment of Tinea Product Portfolio
- 12.11.5 Jiangsu Yunyang Group Pharmaceuticals Recent Developments
- 12.12 Hubei Hengan Fulin
- 12.12.1 Hubei Hengan Fulin Company Information
- 12.12.2 Hubei Hengan Fulin Business Overview
- 12.12.3 Hubei Hengan Fulin Revenue in Fungal Drugs for Treatment of Tinea Business (2021-2026)
- 12.12.4 Hubei Hengan Fulin Fungal Drugs for Treatment of Tinea Product Portfolio
- 12.12.5 Hubei Hengan Fulin Recent Developments
- 12.13 Hainan Kangzhi Pharmaceuticals
- 12.13.1 Hainan Kangzhi Pharmaceuticals Company Information
- 12.13.2 Hainan Kangzhi Pharmaceuticals Business Overview
- 12.13.3 Hainan Kangzhi Pharmaceuticals Revenue in Fungal Drugs for Treatment of Tinea Business (2021-2026)
- 12.13.4 Hainan Kangzhi Pharmaceuticals Fungal Drugs for Treatment of Tinea Product Portfolio
- 12.13.5 Hainan Kangzhi Pharmaceuticals Recent Developments
- 12.14 Harbin Sanlian Pharmaceuticals
- 12.14.1 Harbin Sanlian Pharmaceuticals Company Information
- 12.14.2 Harbin Sanlian Pharmaceuticals Business Overview
- 12.14.3 Harbin Sanlian Pharmaceuticals Revenue in Fungal Drugs for Treatment of Tinea Business (2021-2026)
- 12.14.4 Harbin Sanlian Pharmaceuticals Fungal Drugs for Treatment of Tinea Product Portfolio
- 12.14.5 Harbin Sanlian Pharmaceuticals Recent Developments
- 12.15 Guilin Huaxin Pharmaceuticals
- 12.15.1 Guilin Huaxin Pharmaceuticals Company Information
- 12.15.2 Guilin Huaxin Pharmaceuticals Business Overview
- 12.15.3 Guilin Huaxin Pharmaceuticals Revenue in Fungal Drugs for Treatment of Tinea Business (2021-2026)
- 12.15.4 Guilin Huaxin Pharmaceuticals Fungal Drugs for Treatment of Tinea Product Portfolio
- 12.15.5 Guilin Huaxin Pharmaceuticals Recent Developments
- 12.16 GSK
- 12.16.1 GSK Company Information
- 12.16.2 GSK Business Overview
- 12.16.3 GSK Revenue in Fungal Drugs for Treatment of Tinea Business (2021-2026)
- 12.16.4 GSK Fungal Drugs for Treatment of Tinea Product Portfolio
- 12.16.5 GSK Recent Developments
- 12.17 Chengdu Beite Pharmaceuticals
- 12.17.1 Chengdu Beite Pharmaceuticals Company Information
- 12.17.2 Chengdu Beite Pharmaceuticals Business Overview
- 12.17.3 Chengdu Beite Pharmaceuticals Revenue in Fungal Drugs for Treatment of Tinea Business (2021-2026)
- 12.17.4 Chengdu Beite Pharmaceuticals Fungal Drugs for Treatment of Tinea Product Portfolio
- 12.17.5 Chengdu Beite Pharmaceuticals Recent Developments
- 12.18 Bayer
- 12.18.1 Bayer Company Information
- 12.18.2 Bayer Business Overview
- 12.18.3 Bayer Revenue in Fungal Drugs for Treatment of Tinea Business (2021-2026)
- 12.18.4 Bayer Fungal Drugs for Treatment of Tinea Product Portfolio
- 12.18.5 Bayer Recent Developments
- 12.19 Ultratech India
- 12.19.1 Ultratech India Company Information
- 12.19.2 Ultratech India Business Overview
- 12.19.3 Ultratech India Revenue in Fungal Drugs for Treatment of Tinea Business (2021-2026)
- 12.19.4 Ultratech India Fungal Drugs for Treatment of Tinea Product Portfolio
- 12.19.5 Ultratech India Recent Developments
- 12.20 Perrigo
- 12.20.1 Perrigo Company Information
- 12.20.2 Perrigo Business Overview
- 12.20.3 Perrigo Revenue in Fungal Drugs for Treatment of Tinea Business (2021-2026)
- 12.20.4 Perrigo Fungal Drugs for Treatment of Tinea Product Portfolio
- 12.20.5 Perrigo Recent Developments
- 12.21 Padagis
- 12.21.1 Padagis Company Information
- 12.21.2 Padagis Business Overview
- 12.21.3 Padagis Revenue in Fungal Drugs for Treatment of Tinea Business (2021-2026)
- 12.21.4 Padagis Fungal Drugs for Treatment of Tinea Product Portfolio
- 12.21.5 Padagis Recent Developments
- 12.22 Kaken Pharmaceutical
- 12.22.1 Kaken Pharmaceutical Company Information
- 12.22.2 Kaken Pharmaceutical Business Overview
- 12.22.3 Kaken Pharmaceutical Revenue in Fungal Drugs for Treatment of Tinea Business (2021-2026)
- 12.22.4 Kaken Pharmaceutical Fungal Drugs for Treatment of Tinea Product Portfolio
- 12.22.5 Kaken Pharmaceutical Recent Developments
- 12.23 Gufic Biosciences
- 12.23.1 Gufic Biosciences Company Information
- 12.23.2 Gufic Biosciences Business Overview
- 12.23.3 Gufic Biosciences Revenue in Fungal Drugs for Treatment of Tinea Business (2021-2026)
- 12.23.4 Gufic Biosciences Fungal Drugs for Treatment of Tinea Product Portfolio
- 12.23.5 Gufic Biosciences Recent Developments
- 12.24 Galderma
- 12.24.1 Galderma Company Information
- 12.24.2 Galderma Business Overview
- 12.24.3 Galderma Revenue in Fungal Drugs for Treatment of Tinea Business (2021-2026)
- 12.24.4 Galderma Fungal Drugs for Treatment of Tinea Product Portfolio
- 12.24.5 Galderma Recent Developments
- 12.25 Bausch Health
- 12.25.1 Bausch Health Company Information
- 12.25.2 Bausch Health Business Overview
- 12.25.3 Bausch Health Revenue in Fungal Drugs for Treatment of Tinea Business (2021-2026)
- 12.25.4 Bausch Health Fungal Drugs for Treatment of Tinea Product Portfolio
- 12.25.5 Bausch Health Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$2,950USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst